top of page
DANIEL DELITTO, MD, PhD
Innovation
We have shown that fibroblasts can profoundly suppress T cell function, preventing the immune system from killing cancer cells (Link to Cancer Research manuscript from 2017).
We are now developing therapies to dismantle this protective effect of fibroblasts, allowing the immune
system to target and eliminate pancreatic cancer cells.
Fibroblast-mediated Suppression
of T Cell Function
in Pancreatic Cancer
Our commitment involves
training new scientists
for the next generations
Funding
Funding
bottom of page